Goldman Sachs Sees Financing Fees Rise to 40% of Revenue by 2026

Goldman Sachs' (GS) revenue is projected to see a significant shift in its revenue streams, with financing fees expected to account for around 40% of the company's revenue by 2026. This represents an increase from approximately 27% in 2023, indicating that financing will become an increasingly important source of income for Goldman Sachs.

The trend is reflected in a recent deal where Goldman Sachs' Alternatives life-sciences arm co-led a $152 million financing for Swiss biotech Vaderis. This funding will support the company's late-stage trial of engasertib, a treatment aimed at hereditary hemorrhagic telangiectasia.

In another development, Goldman Sachs has appointed Chandresh Chheda as MD and co-head of India investment banking in Mumbai. He joins from JPMorgan and will help expand Goldman Sachs' regional franchise in the Asia Pacific region.